Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Disopyramide phosphate 100mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Some |
|
Disopyramide phosphate 150mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Some |
|
Disopyramide phosphate 100mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Some |
|
Disopyramide phosphate 150mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Some |
|
Disopyramide phosphate 100mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Some |
|
Product containing precisely disopyramide phosphate 100 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Some |
|
Product containing precisely disopyramide phosphate 150 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Some |
|
Product containing precisely disopyramide phosphate 100 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Some |
1 |
Product containing precisely disopyramide phosphate 100 milligram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Disopyramide phosphate |
Inferred relationship |
Some |
1 |
Product containing precisely disopyramide phosphate 150 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Some |
1 |
Product containing precisely disopyramide phosphate 150 milligram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Disopyramide phosphate |
Inferred relationship |
Some |
1 |
Disopyramide phosphate 100mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Some |
|
Disopyramide phosphate 150mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Some |
|
Disopyramide phosphate 100mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Disopyramide phosphate |
Inferred relationship |
Some |
|
Disopyramide (as disopyramide phosphate) 250 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Disopyramide phosphate |
Inferred relationship |
Some |
1 |
Disopyramide (as disopyramide phosphate) 150 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Disopyramide phosphate |
Inferred relationship |
Some |
1 |
Disopyramide (as disopyramide phosphate) 250 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Disopyramide phosphate |
Inferred relationship |
Some |
1 |
Product containing precisely disopyramide phosphate 100 milligram/1 each conventional release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Disopyramide phosphate |
Inferred relationship |
Some |
1 |
Product containing precisely disopyramide phosphate 150 milligram/1 each conventional release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Disopyramide phosphate |
Inferred relationship |
Some |
1 |
Product containing precisely disopyramide (as disopyramide phosphate) 50 milligram/5 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Disopyramide phosphate |
Inferred relationship |
Some |
1 |
Disopyramide (as disopyramide phosphate) 10 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Disopyramide phosphate |
Inferred relationship |
Some |
1 |
Product containing precisely disopyramide (as disopyramide phosphate) 100 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Disopyramide phosphate |
Inferred relationship |
Some |
1 |
Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Disopyramide phosphate |
Inferred relationship |
Some |
1 |